no difference was found in the incidence of septicemia or of all bacterial infections between the patients with aluminum-related bone disease treated with desferrioxamine and the control patients ( 0.12 vs. 0.12 septicemia per patient-therapy-year , p greater than 0.05 ; 0.23 vs. 0.26 bacterial infections per patient-therapy-year , p greater than 0.05 ) .
C0004623
bacterial infections
C0036690
septicemia